Detalles de la búsqueda
1.
Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 18(11): 1467-1482, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28958504
2.
A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)-only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer.
Gynecol Oncol
; 146(3): 484-490, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28698009
3.
Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study.
Int J Gynecol Cancer
; 27(1): 50-58, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27749456
4.
Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.
Lancet Oncol
; 15(9): 1007-18, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24965569
5.
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
Lancet Oncol
; 14(8): 697-710, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23746666
6.
Reversible holographic recording media based on polymeric composites and their use in energy-saving technologies.
Appl Opt
; 51(10): C48-54, 2012 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22505111
7.
Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.
JAMA
; 304(19): 2154-60, 2010 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-21081728
8.
Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer.
Clin Cancer Res
; 20(16): 4240-50, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24919569
9.
Sorafenib in combination with oxaliplatin, leucovorin, and fluorouracil (modified FOLFOX6) as first-line treatment of metastatic colorectal cancer: the RESPECT trial.
Clin Cancer Res
; 19(9): 2541-50, 2013 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23532888
10.
Randomized, multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma: including a prospective evaluation of the role of hENT1 in gemcitabine or CO-101 sensitivity.
J Clin Oncol
; 31(35): 4453-61, 2013 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24220555
11.
Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.
J Clin Oncol
; 27(26): 4333-8, 2009 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19636011
Resultados
1 -
11
de 11
1
Próxima >
>>